Anesthesia and Respiratory Devices Market Set for Significant Growth, Projected to Reach USD 73 Billion by 2030
According to Next Move Strategy Consulting, the global Anesthesia and Respiratory Devices Market is expected to grow to USD 73 billion by 2030, reflecting a robust CAGR of 7% from 2023 to 2030. This significant market growth is being driven by rising rates of chronic respiratory conditions, an increasing number of surgical procedures, and the growing healthcare needs of an aging population worldwide.
Download FREE Sample Report: https://www.nextmsc.com/anesthesia-respiratory-devices-market/request-sample
What Are Anesthesia and Respiratory Devices?
Anesthesia devices are used during surgeries to manage and regulate essential bodily functions, including pain, blood pressure, heart rate, and respiration, while ensuring the patient remains unconscious and comfortable. These devices deliver controlled amounts of anesthetic gases, medications, and oxygen to the patient, facilitating safe and effective surgeries.
Respiratory care devices, on the other hand, are used for diagnosing and treating respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and sleep apnea. These devices include ventilators, nebulizers, inhalers, oxygen concentrators, and other tools designed to support breathing and lung function.
Key Drivers of Market Growth
- Increasing Prevalence of Respiratory Diseases: Respiratory conditions, such as asthma, COPD, and sleep apnea, are on the rise globally. According to the World Health Organization (WHO), asthma affects an estimated 262 million people, contributing to 455,000 deaths in 2019 alone. This growing disease burden is significantly increasing the demand for respiratory devices, including oxygen concentrators, ventilators, nebulizers, and inhalers.
- Rising Surgical Procedures: As the number of surgeries—both inpatient and outpatient—continues to increase, so does the demand for anesthesia devices. These devices are essential for maintaining patient safety and comfort during a wide range of surgical interventions. The global rise in healthcare expenditures is also contributing to the widespread adoption of anesthesia and respiratory devices.
- Aging Global Population: As the global population continues to age, there is a marked increase in age-related chronic conditions such as COPD, heart disease, and respiratory failure. According to the WHO, the proportion of people aged over 60 is expected to nearly double between 2015 and 2050, from 12% to 22% of the global population. This demographic shift is fueling the demand for both respiratory and anesthesia devices.
- Technological Innovations: Advancements in artificial intelligence (AI) and machine learning are expected to propel the market forward by creating smarter anesthesia and respiratory devices. These technologies can automatically adjust to patients' needs in real time, improving care quality and operational efficiency. AI also facilitates data analysis, allowing healthcare providers to make more informed decisions for patient management.
Inquiry Before Buying: https://www.nextmsc.com/anesthesia-respiratory-devices-market/inquire-before-buying
Market Segmentation and Scope
The global Anesthesia and Respiratory Devices Market is segmented by type, end user, and region:
- By Type:
- Anesthesia Devices: Machines (delivery machines, monitors, ventilators, workstations), Disposables (disposable masks, accessories)
- Respiratory Devices: Equipment (positive airway pressure, bi-level pressure devices), Ventilators (adult and neonatal), Nebulizers (pneumatic, mesh, ultrasonic), Humidifiers, Inhalers (dry powder, metered-dose), Oxygen concentrators, Disposables (oxygen masks, cannula), Measurement Devices (pulse oximeters, spirometers)
- By End User: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others
- By Region: North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Regional Insights
North America currently holds the largest market share, driven by high healthcare spending, advanced healthcare infrastructure, and the rising prevalence of cardiovascular diseases that often require surgical interventions. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending reached USD 4.3 trillion in 2021, further fueling the demand for anesthesia and respiratory devices.
In Asia-Pacific, the growing elderly population and increasing rates of chronic diseases, such as COPD, asthma, and sleep apnea, are creating significant demand for respiratory care devices. Countries like China and Japan are seeing increased adoption of respiratory devices like ventilators, nebulizers, and oxygen concentrators, driven by rising healthcare awareness and the need for improved treatment of chronic respiratory conditions.
Competitive Landscape
The anesthesia and respiratory devices market is highly competitive, with major players investing in product innovation, strategic partnerships, and expanding their market reach. Key companies operating in the market include:
- Teleflex Incorporated
- Sunmed
- Smiths Group Plc.
- Resmed, Inc.
- Medtronic Plc.
- Masimo Corporation
- Koninklijke Philips
- Invacare Corporation
- Hamilton Medical AG
- Mdoloris Medical Systems
Notable industry developments include Koninklijke Philips launching its Philips Lung Suite in 2022, a revolutionary 3D imaging platform aimed at enhancing early lung cancer diagnosis and treatment. Additionally, Mdoloris Medical Systems received regulatory clearance for its HFVI MOC-9 monitor in Japan, designed for patients undergoing anesthesia, signaling the growing adoption of advanced monitoring technologies in the region.
Challenges and Opportunities
Despite the promising growth prospects, the market faces challenges such as the high cost of advanced devices and slow adoption of new technologies in low-income regions. Additionally, the market is hindered by the reluctance of healthcare providers to adopt expensive and complex technologies. However, opportunities abound with the development of AI-powered devices, which offer the potential for cost-effective, real-time monitoring and adjustment, and increased access to advanced care in underserved regions.
Also, Browse Related Reports:
For more information, please contact:
Next Move Strategy Consulting
E-Mail: info@nextmsc.com
Direct: +1-217-650-7991
Website: www.nextmsc.com
Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube
About Next Move Strategy Consulting:
Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.